These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33059006)

  • 1. Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.
    Nguyen PV; Hervé-Aubert K; David S; Lautram N; Passirani C; Chourpa I; Aubrey N; Allard-Vannier E
    Eur J Pharm Biopharm; 2020 Dec; 157():74-84. PubMed ID: 33059006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis.
    Ben Djemaa S; David S; Hervé-Aubert K; Falanga A; Galdiero S; Allard-Vannier E; Chourpa I; Munnier E
    Eur J Pharm Biopharm; 2018 Oct; 131():99-108. PubMed ID: 30063968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of CD44s-siRNA by ScFv overcomes de novo resistance to cetuximab in triple negative breast cancer.
    Fu W; Sun H; Zhao Y; Chen M; Yang L; Yang X; Jin W
    Mol Immunol; 2018 Jul; 99():124-133. PubMed ID: 29777999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines.
    Nguyen PV; Allard-Vannier E; Aubrey N; Labrugère-Sarroste C; Chourpa I; Sobilo J; Le Pape A; Hervé-Aubert K
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.
    Bruniaux J; Allard-Vannier E; Aubrey N; Lakhrif Z; Ben Djemaa S; Eljack S; Marchais H; Hervé-Aubert K; Chourpa I; David S
    Int J Pharm; 2019 Oct; 569():118572. PubMed ID: 31352052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
    Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
    Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
    Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
    J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.
    Tang J; Howard CB; Mahler SM; Thurecht KJ; Huang L; Xu ZP
    Nanoscale; 2018 Mar; 10(9):4258-4266. PubMed ID: 29436549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA-loaded poly(histidine-arginine)
    Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
    Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
    Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
    Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
    Liu L; Li H; Zhang M; Lv X
    Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.